Saving money is wise, but investing is profitable
In accordance with the legislation of the Czech Republic, the Company provides services only to qualified investors!

Debut trading of Achilles Therapeutics, Inc.

01.04.2021

In its debut trading on Wednesday, March 31 Achilles Therapeutics, Inc. (ACHL) decreased 8.06% and closed at $16.55 per share. Shortly before the company had placed its shares in IPO priced $18 per share.